Honorary General Treasurer

David Edmonds

Presently Principal of CMC Regulatory, commenced February 2008. CMC Regulatory advises to therapeutic goods R&D companies and manufacturers regards to the Regulatory and GMP/auditing requirements in the manufacture and testing of active pharmaceutical ingredients and medicinal dose form, in Australia and elsewhere. Specialisation in the preparation of chemistry/manufacture/(quality) control (CMC) documentation for clinical trials and laboratory data review.

Previously Manager, Quality Assurance and Regulatory Affairs at Peptech Limited for over 20 years and held QA. Manufacturing and Laboratory management positions at A.H. Robins Pty Ltd, Lilly Industries, Crystal Products and Sterling Pharmaceuticals during the previous 20 years.

From 1987 to 2008, Quality Assurance Manager for Peptech Limited, responsible for Quality Assurance and Regulatory Affairs. This included manufacturing and laboratory documentation and procedures under principles of GMP for products for human clinical trials and commercial veterinary implants. Responsibilities also included preparation and submission of CMC documentation to Australian TGA, US FDA and UK and European Therapeutic Goods Agencies.